Cargando…
State‐of‐the‐art of lumbar puncture and its place in the journey of patients with Alzheimer's disease
Recent advances in developing disease‐modifying therapies (DMT) for Alzheimer's disease (AD), and the recognition that AD pathophysiology emerges decades before clinical symptoms, necessitate a paradigm shift of health‐care systems toward biomarker‐guided early detection, diagnosis, and therape...
Autores principales: | Hampel, Harald, Shaw, Leslie M., Aisen, Paul, Chen, Christopher, Lleó, Alberto, Iwatsubo, Takeshi, Iwata, Atsushi, Yamada, Masahito, Ikeuchi, Takeshi, Jia, Jianping, Wang, Huali, Teunissen, Charlotte E., Peskind, Elaine, Blennow, Kaj, Cummings, Jeffrey, Vergallo, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626532/ https://www.ncbi.nlm.nih.gov/pubmed/34043269 http://dx.doi.org/10.1002/alz.12372 |
Ejemplares similares
-
The Amyloid-β Pathway in Alzheimer’s Disease
por: Hampel, Harald, et al.
Publicado: (2021) -
The amyloid-β pathway in Alzheimer's disease: a plain language summary
por: Hampel, Harald, et al.
Publicado: (2023) -
Evaluation of major national dementia policies and health‐care system preparedness for early medical action and implementation
por: Hampel, Harald, et al.
Publicado: (2022) -
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
por: Olsson, Martin, et al.
Publicado: (2019) -
Consensus guidelines for lumbar puncture in patients with neurological diseases
por: Engelborghs, Sebastiaan, et al.
Publicado: (2017)